SGLT2: new approaches to combination therapy of type 2 diabetes mellitus

• Main Authors: I. V. Kononenko, O. M. Smirnova
• Format: Article
• Language: Russian
• Published: Remedium Group LLC 2016-12-01
• Series: Медицинский совет
• Subjects: сахарный диабет 2-го типа; комбинированная терапия; инсулинорезистентность; дисфункция бета-клеток; метформин; ингибитор sglt2; дапаглифлозин; type 2 diabetes; combination therapy; insulin resistance; beta cell dysfunction; metformin; sglt2 inhibitor; dap
• Online Access: https://www.med-sovet.pro/jour/article/view/53

Despite the emergence of new antidiabetic drugs, diabetes type 2 treatment remains a relevant issue. In order to standardize and optimize medical care to patients with diabetes, global and national algorithms for type 2 diabetes treatment were developed. [1, 2] The current algorithms focus on an individual approach, safety and effectiveness of treatment. A balance should be maintained between achieving optimal glycemic control and safety of therapy.